RecruitingNCT07359898

International Multicenter Study of the Navitor/Navitor Vision Transcatheter Aortic Valve Platform

International Multicenter Study of the Navitor/Navitor Vision Transcatheter Aortic Valve Platform (The Intensive Study)

Sponsor

IRCCS Policlinico S. Donato

Enrollment

1,000 participants

Start Date

Oct 11, 2025

Study Type

OBSERVATIONAL

Conditions

Severe Native Aortic Stenosis

Summary

INTENSIVE is a prospective, single-arm, multi-center, international, investigator-initiated study of the Navitor/Navitor Vision Transcatheter Aortic Valve (Navitor/Navitor Vision Valve) in patients with symptomatic, severe native aortic stenosis to monitor the outcomes of this valve in a real-world clinical setting.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with severe native aortic stenosis. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(1)

IRCCS Policlinico San Donato

San Donato Milanese, Lombardy, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07359898